CML Blood Cancer Treatment in India at an Affordable Price
CML blood cancer treatment in India is available at an affordable price at various hospitals of Mumbai, Bangalore, Hyderabad, Chennai and New Delhi. India has emerged as the favorite medical tourism destination because of the availability of a variety of high-quality and affordable price medical procedures. India’s private hospitals have gained international recognition for their state-of-the-art facilities and diagnostic centers besides unsurpassed skills. Their technology and procedures are at par with hospitals in developed nations. The super-specialty chosen by various Indian hospitals as its area of focus includes Oncology.
Definition of CML Blood Cancer
CML Blood Cancer (chronic myelogenous leukemia) is cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The CML Blood Cancer grows from cells that produce white blood cells.
Causes of CML Blood Cancer
Exposure to ionizing radiation is one possible trigger for CML Blood Cancer. Such exposure could occur from a nuclear disaster or from treatment of a previous cancer such as thyroid cancer or Hodgkin's lymphoma. It takes many years to develop leukemia from this cause. However, most people treated for cancer with radiation do not go on to develop leukemia, and most patients with CML Blood Cancer have not been exposed to radiation.
Symptoms of CML Blood Cancer
CML Blood Cancer causes rapid growth of the blood-forming cells (myeloid precursors) in the bone marrow, blood, and body tissues.
CML Blood Cancer is grouped into several phases –
- Blast crisis
The chronic phase can last for months or years. CML Blood Cancer may have few or no symptoms during this time. Most people are diagnosed with CML Blood Cancer during this stage, when they are having blood drawn for other reasons. The accelerated phase of CML Blood Cancer is a more dangerous phase, during which the leukemia cells grow more quickly. This phase may be associated with fever (without infection), bone pain, and a swollen spleen.
If untreated, CML Blood Cancer progresses to the blast crisis phase. Bleeding and infection may occur due to bone marrow failure.
Other possible symptoms of CML Blood Cancer include –
- Bleeding and bruising
- Excessive sweating (night sweats)
- Low-grade fever
- Pressure under the left ribs from a swollen spleen
- Sudden appearance of small red marks on the skin (petechiae)
Treatment for CML Blood Cancer
Imatinib (Gleevec) is the first therapy for everyone with CML Blood Cancer. Gleevec blocks the Philadelphia chromosome and is associated with very high rates of remission. New medications include dasatinib (Sprycel) and nilotinib (Tasigna). They work in a similar way as imatinib. Sometimes a chemotherapy medicine called hydroxyurea (Hydrea) is used temporarily to control the white blood cell count. The blast crisis phase is very difficult to treat, because it is marked by a very high count of immature white blood cells (leukemia cells). It is treated similarly to acute myeloid leukemia (AML). The only known cure for CML Blood Cancer is a bone marrow transplant or stem cell transplant. You should discuss your options in detail with your oncologist.
Why consider India?
CML blood cancer treatment in India is available at various hospitals that are fully equipped with the latest medical technology. Indian Hospitals are a good option for international patients who are seeking high quality, affordable price medical treatment away from their homes as they are designed in strict accordance with International guidelines. These hospitals are offering not only the basic hospital treatment like surgery, radiotherapy or chemotherapy but also intensive rehabilitation programmes and follow up care. Indian Hospitals aim at creating an integrated world-class healthcare system by leveraging the best medical practices backed by cutting-edge technology.
To get free no obligation Quote for CML Blood Cancer Treatment in India: click here
To read international patient’s experiences: click here
For information on Oncology: click here